Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 21,383Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2NanoAlvand

02 2Aurobindo Pharma Limited

03 27Eli Lilly

04 1Health Biotech

05 3MSN Laboratories

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Baricitinib

Brand Name : Intyma

Dosage Form : Film Coated Tablet

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Baricitinib

Brand Name : Intyma

Dosage Form : Film Coated Tablet

Dosage Strength : 4MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

03

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

BARICITINIB

Brand Name : BARICITINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2024-07-22

Application Number : 217542

Regulatory Info : DISCN

Registration Country : USA

blank

04

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

BARICITINIB

Brand Name : BARICITINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2024-07-22

Application Number : 217542

Regulatory Info : DISCN

Registration Country : USA

blank

05

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

BARICITINIB

Brand Name : OLUMIANT

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2018-05-31

Application Number : 207924

Regulatory Info : RX

Registration Country : USA

blank

06

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

BARICITINIB

Brand Name : OLUMIANT

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2019-10-08

Application Number : 207924

Regulatory Info : RX

Registration Country : USA

blank

07

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

BARICITINIB

Brand Name : OLUMIANT

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2022-05-10

Application Number : 207924

Regulatory Info : RX

Registration Country : USA

blank

08

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Baricitinib

Brand Name : Olumiant

Dosage Form : Film Coated Tablet

Dosage Strength :

Packaging :

Approval Date : 15/09/2023

Application Number : 20220912000088

Regulatory Info : Approved

Registration Country : Sweden

blank

09

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Baricitinib

Brand Name : Olumiant

Dosage Form : Film Coated Tablet

Dosage Strength : 2mg

Packaging :

Approval Date : 13/02/2017

Application Number : 20160127000018

Regulatory Info : Approved

Registration Country : Sweden

blank

10

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Baricitinib

Brand Name : Olumiant

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 13/02/2017

Application Number : 20160127000025

Regulatory Info : Approved

Registration Country : Sweden

blank

11

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Baricitinib

Brand Name : Olumiant

Dosage Form : Film Coated Tablet

Dosage Strength : 2mg

Packaging :

Approval Date : 19/06/2017

Application Number : 66215

Regulatory Info : Allowed

Registration Country : Switzerland

blank

12

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Baricitinib

Brand Name : Olumiant

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date : 19/06/2017

Application Number : 66215

Regulatory Info : Allowed

Registration Country : Switzerland

blank

13

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Baricitinib

Brand Name : Olumiant

Dosage Form : Film Coated Tablet

Dosage Strength : 2mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Not Marketed

Registration Country : Norway

blank

14

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Baricitinib

Brand Name : Olumiant

Dosage Form : Film Coated Tablet

Dosage Strength : 2mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

15

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Baricitinib

Brand Name : Olumiant

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Not Marketed

Registration Country : Norway

blank

16

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Baricitinib

Brand Name : Olumiant

Dosage Form : Film Coated Tablet

Dosage Strength : 4mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

17

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

Baricitinib

Brand Name :

Dosage Form : Tablet

Dosage Strength : 4MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

18

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

BARICITINIB

Brand Name : OLUMIANT

Dosage Form : TABLET;ORAL

Dosage Strength : 1MG

Packaging :

Approval Date : 2025-08-08

Application Number : 217585

Regulatory Info : RX

Registration Country : USA

blank

19

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

BARICITINIB

Brand Name : OLUMIANT

Dosage Form : TABLET;ORAL

Dosage Strength : 2MG

Packaging :

Approval Date : 2025-08-08

Application Number : 217585

Regulatory Info : RX

Registration Country : USA

blank

20

SCOPE Summit
Not Confirmed
arrow
arrow
SCOPE Summit
Not Confirmed

BARICITINIB

Brand Name : OLUMIANT

Dosage Form : TABLET;ORAL

Dosage Strength : 4MG

Packaging :

Approval Date : 2025-08-08

Application Number : 217585

Regulatory Info : RX

Registration Country : USA

blank